MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617017787 A) filed by Keymed Biosciences Co. Ltd., Sichuan, China, on Feb. 17, for 'development and use of therapeutic agent for alzheimer's disease.'
Inventor(s) include Chen, Bo; Xu, Gang; Guo, Bujing; and Hou, Qiaoyun.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "Provided is an antibody that binds to -amyloid (A), or an antigen-binding fragment thereof. Further provided are a nucleic acid encoding the antibody or the antigen-binding fragment thereof, a cell comprising the antibody or the antigen-binding fragment or nucleic acid thereof, a pharmaceutical composition, a kit, and the use of the antibody or the antigen-binding fragment thereof in the preparation of a drug used for treating or preventing a disease caused by abnormal accumulation or deposition of A in subjects."
The patent application was internationally filed on Aug. 23, 2024, under International application No.PCT/CN2024/114232.
Disclaimer: Curated by HT Syndication.
